{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:35:10Z","timestamp":1760056510294,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H05215","25460630","25460777"],"award-info":[{"award-number":["16H05215","25460630","25460777"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ccl.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T09:55:05Z","timestamp":1618998905000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting the Role of Guideline-Directed Medical Therapy for Patients with Heart Failure and Severe Functional Mitral Regurgitation"],"prefix":"10.1016","volume":"39","author":[{"given":"Shun","family":"Kohsaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Saji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2021.01.008_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics \u2013 2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2021.01.008_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1540-8191.2011.01274.x","article-title":"Prevalence of the different Carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development","volume":"26","author":"de Marchena","year":"2011","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.ccl.2021.01.008_bib3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2017.2976","article-title":"Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis","volume":"2","author":"Sannino","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ccl.2021.01.008_bib4","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2021.01.008_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in HF","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.72.1.63","article-title":"Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial","volume":"72","author":"Seneviratne","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccl.2021.01.008_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/hrt.2002.009696","article-title":"The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodeling in response to carvedilol: size does not matter","volume":"90","author":"Kotlyar","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2021.01.008_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","article-title":"Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol","volume":"139","author":"Capomolla","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2021.01.008_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jchf.2017.06.015","article-title":"Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction","volume":"5","author":"Nasser","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccl.2021.01.008_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.110.009803","article-title":"Cardiac resynchronization therapy is a therapeutic option in patients with moderate-to-severe functional mitral regurgitation and high operative risk","volume":"124","author":"van Bommel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2021.01.008_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0735-1097(02)02937-6","article-title":"Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in patients with advanced systolic heart failure","volume":"41","author":"Breithardt","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2021.01.008_bib13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.112.000112","article-title":"Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcomes","volume":"6","author":"Onishi","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2021.01.008_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.athoracsur.2007.11.021","article-title":"The recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in patients with advanced dilated cardiomyopathy","volume":"85","author":"De Bonis","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccl.2021.01.008_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5223(98)70282-X","article-title":"Intermediate-term outcome of mitral reconstruction in cardiomyopathy","volume":"115","author":"Bolling","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ccl.2021.01.008_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2002-35746","article-title":"Mitral valve surgery in patients with poor left ventricular function","volume":"50","author":"Rothenburger","year":"2002","journal-title":"Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.ccl.2021.01.008_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1010-7940(03)00148-9","article-title":"Mitral valve repair in patients with end-stage cardiomyopathy: who benefits?","volume":"23","author":"Gummert","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ccl.2021.01.008_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1010-7940(00)00345-6","article-title":"Mitral valve surgery in patients with severe left ventricular dysfunction","volume":"17","author":"Bishay","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ccl.2021.01.008_bib22","first-page":"II124","article-title":"Mitral valve repair in cardiomyopathy","volume":"98","author":"Chen","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2021.01.008_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","article-title":"Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction","volume":"45","author":"Wu","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ccl.2021.01.008_bib24","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.jacc.2020.02.005","article-title":"2020 focused update of the 2017 ACC Expert Consensus Decision Pathway on the management of mitral regurgitation: a report of the American College of cardiology Solution Set Oversight committee","volume":"75","author":"Bonow","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ccl.2021.01.008_bib25","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","article-title":"Atrial functional mitral regurgitation: JACC review topic of the week","volume":"73","author":"Deferm","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2021.01.008_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.athoracsur.2013.10.044","article-title":"Similar survival after mitral valve replacement or repair for ischemic mitral regurgitation: a meta-analysis","volume":"97","author":"Dayan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccl.2021.01.008_bib27","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","article-title":"Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials","volume":"12","author":"Grayburn","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccl.2021.01.008_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2019.5971","article-title":"New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation","volume":"5","author":"Packer","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ccl.2021.01.008_bib31","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2021.01.008_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.119.039612","article-title":"Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure","volume":"140","author":"Packer","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2021.01.008_bib33","article-title":"Impact of mitral regurgitation severity and left ventricular remodeling on outcomes after Mitraclip implantation: results from the Mitra-FR trial","author":"Messika-Zeitoun","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccl.2021.01.008_bib34","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jcmg.2019.05.005","article-title":"Disproportionate functional mitral regurgitation: advancing a conceptual framework to clinical practice","volume":"12","author":"Bartko","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccl.2021.01.008_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib36","first-page":"108","article-title":"Ejection fraction improvement and reverse remodeling achieved with sacubitril\/valsartan in patients with heart failure with reduced ejection fraction","volume":"7","author":"Almufleh","year":"2017","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.ccl.2021.01.008_bib37","doi-asserted-by":"crossref","first-page":"e12435","DOI":"10.1111\/1755-5922.12435","article-title":"The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","volume":"36","author":"Martens","year":"2018","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ccl.2021.01.008_bib38","first-page":"100418","article-title":"Impact of sacubitril\/valsartan on echo parameters in heart failure patients with reduced ejection fraction: a prospective evaluation","volume":"25","author":"Bayard","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ccl.2021.01.008_bib39","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor inhibitor neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2021.01.008_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-018-0775-z","article-title":"Impact of dapagliflozin on left ventricular diastolic function in patients with type 2 diabetes mellitus with chronic heart failure","volume":"17","author":"Soga","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccl.2021.01.008_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-018-0717-9","article-title":"Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes","volume":"17","author":"Matsutani","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccl.2021.01.008_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12933-020-0987-x","article-title":"Effects of antidiabetic drugs on left ventricular function\/dysfunction: a systematic review and network meta-analysis","volume":"19","author":"Zhang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccl.2021.01.008_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-019-0985-z","article-title":"Positive effect of dapagliflozin on left ventricular longitudinal function in patients with type 2 diabetes mellitus and chronic heart failure","volume":"19","author":"Tanaka","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccl.2021.01.008_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-019-0910-5","article-title":"Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial","volume":"18","author":"Bonora","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ccl.2021.01.008_bib45","doi-asserted-by":"crossref","first-page":"15348","DOI":"10.1038\/s41598-019-51949-5","article-title":"Effect of empagliflozin on cardiac function, adiposity, and diffuse fibrosis in patients with type 2 diabetes mellitus","volume":"9","author":"Hsu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ccl.2021.01.008_bib46","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc19-2187","article-title":"Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure: the REFORM trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ccl.2021.01.008_bib47","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib48","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2021.01.008_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCHEARTFAILURE.113.000163","article-title":"Practice-level variation in use of recommended medications among outpatients with heart failure insights from the NCDR PINNACLE Program","volume":"6","author":"Peterson","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ccl.2021.01.008_bib50","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians\u2019 adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2021.01.008_bib51","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study","volume":"6","author":"Teng","year":"2018","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.ccl.2021.01.008_bib52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamacardio.2019.5108","article-title":"Global differences in characteristics, precipitants, and initial management of patients presenting with acute heart failure","volume":"5","author":"Filippatos","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ccl.2021.01.008_bib53","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jval.2015.08.005","article-title":"Appropriateness of prescriptions of recommended treatments in Organisation for Economic Co-operation and development health systems: findings based on the long-term registry of the European Society of cardiology on heart failure","volume":"18","author":"Maggioni","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ccl.2021.01.008_bib54","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Maucort-Boulch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2021.01.008_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2017.02.070","article-title":"Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival","volume":"235","author":"Akita","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:52:05Z","timestamp":1760007125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865121000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0733865121000084"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2021.01.008","relation":{},"ISSN":["0733-8651"],"issn-type":[{"type":"print","value":"0733-8651"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the Role of Guideline-Directed Medical Therapy for Patients with Heart Failure and Severe Functional Mitral Regurgitation","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}